The accelerator-based boron neutron capture reaction evaluation system for head and neck cancer.


Journal

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
ISSN: 1872-9800
Titre abrégé: Appl Radiat Isot
Pays: England
ID NLM: 9306253

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 01 10 2019
revised: 26 05 2020
accepted: 04 06 2020
pubmed: 11 8 2020
medline: 28 8 2021
entrez: 11 8 2020
Statut: ppublish

Résumé

The purpose of this study is to assess accelerator-based boron neutron capture reaction (BNCR) in human tumor cell lines by colony formation assay and modified high density survival assay (HDS assay). The results of post irradiation survival rate in human oral squamous cell carcinoma and osteosarcoma using both assays were similar. Therefore, HDS assay would be efficient to evaluate BNCR in not only tumor cells but also in normal cells as BNCT screening.

Identifiants

pubmed: 32771869
pii: S0969-8043(20)30421-8
doi: 10.1016/j.apradiso.2020.109271
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109271

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Shou Wang (S)

Department of Oral and Maxillofacial Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata Kita-ku Okayama, 700-855, Japan.

Kazuyo Igawa (K)

Neutron Therapy Research Center, Okayama University, 2-5-1 Shikata Kita-ku Okayama, 700-855, Japan. Electronic address: igawakazuyo@okayama-u.ac.jp.

Ryo Ogawara (R)

Advanced Research Center for Beam Science, Institute for Chemical Research, Kyoto University, Gokasho, Uji, Kyoto 611-0011, Japan; National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.

Mitsuru Suda (M)

National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.

Tsuyoshi Hamano (T)

National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.

Soichiro Ibaragi (S)

Department of Oral and Maxillofacial Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata Kita-ku Okayama, 700-855, Japan.

Tadashi Hanafusa (T)

Neutron Therapy Research Center, Okayama University, 2-5-1 Shikata Kita-ku Okayama, 700-855, Japan.

Yasuaki Ichikawa (Y)

Neutron Therapy Research Center, Okayama University, 2-5-1 Shikata Kita-ku Okayama, 700-855, Japan.

Akira Sasaki (A)

Department of Oral and Maxillofacial Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata Kita-ku Okayama, 700-855, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH